Table 4 Calculated GI% for target compounds, in series (A) and (B) at (10−5 M) concentration, concerning the most sensitive NCI cancer cell lines.
Compounda | Subpanel/cell line | |||
|---|---|---|---|---|
CNS cancer (SNB-75) | Renal cancer (UO-31) | Breast cancer (MDA-MB-468) | Leukemia (SR) | |
5a | 29 | – | – | – |
5b | 28 | 11 | – | – |
5c | 35 | 11 | – | – |
6a | – | 19 | 18 | 13 |
6b | 28 | – | – | – |
6c | 21 | 16 | – | – |
6d | 30 | 12 | – | – |
6e | – | 11 | – | – |
6f. | 23 | 11 | – | – |
6g | 33 | 14 | – | – |
6h | – | 17 | – | – |
6i | – | 14 | – | – |
6j | 29 | 17 | – | – |
7a | – | 12 | – | – |
8a | 14 | 17 | – | – |
8b | 21 | – | 11 | 15 |
8c | – | – | – | – |
10 | 33 | – | – | – |
12a | – | – | – | – |
12b | 14 | 16 | 16 | 14 |
12c | – | 14 | 22 | 16 |
12d | 12 | 14 | 62 | 51 |
12e | – | 13 | 27 | 11 |
12f. | 10 | 15 | 15 | 11 |
12g | 15 | 11 | 11 | – |
12h | – | – | 11 | 27 |
12i | – | 20 | 17 | – |
12j | 11 | 14 | – | – |